Walcott Brian P, Iorgulescu J Bryan, Stapleton Christopher J, Kamel Hooman
Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, White Building Room 502, Boston, MA, 02114, USA,
Neurocrit Care. 2015 Aug;23(1):54-8. doi: 10.1007/s12028-014-0072-y.
Although hydrocephalus is often treated with permanent cerebrospinal fluid (CSF) shunting during hospitalization for acute aneurysmal subarachnoid hemorrhage (SAH), little is known about the development of delayed hydrocephalus.
Using administrative data on all visits to nonfederal emergency departments and acute care hospitals across California from 2005 to 2010, we identified patients with SAH and discharged without placement of a CSF shunt. Patients were followed for up to 7 years to determine whether they subsequently developed delayed hydrocephalus, as indicated by hospitalization for a permanent CSF diversion procedure.
In 8,889 patients discharged with SAH, 116 (1.3 %) went on to develop delayed hydrocephalus. Most (>90 %) diagnoses of delayed hydrocephalus occurred within the first year after discharge. Cox proportional hazards analysis identified microsurgical clipping (hazard ratio 2.0; 95 % confidence interval 1.2-3.3), temporary ventriculostomy placement (2.5; 1.6-4.1), mechanical ventilation (1.7; 1.1-2.8), and discharge to a skilled nursing facility (2.9; 1.8-4.6) as being significantly associated with the development of delayed hydrocephalus. At 1 year after discharge, the cumulative rate of delayed hydrocephalus was 0.9 % (95 % CI, 0.7-1.1 %) for those without temporary ventriculostomy placement during the initial hospitalization, versus 5.7 % (95 % CI, 3.9-8.1 %) in those who had received a temporary ventriculostomy.
Delayed hydrocephalus after SAH occurs rarely overall, but in a substantial proportion of patients who required temporary ventriculostomy during the initial hospitalization. These results support vigilant surveillance of patients after removal of a temporary ventriculostomy, given the potential of delayed hydrocephalus to impair recovery or even result in clinical deterioration following SAH.
虽然在急性动脉瘤性蛛网膜下腔出血(SAH)住院期间,脑积水常通过永久性脑脊液(CSF)分流术进行治疗,但对于迟发性脑积水的发生情况知之甚少。
利用2005年至2010年加利福尼亚州所有非联邦急诊科和急性护理医院的就诊管理数据,我们确定了患有SAH且出院时未放置CSF分流装置的患者。对患者进行长达7年的随访,以确定他们随后是否发生迟发性脑积水,这通过永久性CSF分流手术的住院情况来表明。
在8889例SAH出院患者中,116例(1.3%)随后发生迟发性脑积水。大多数(>90%)迟发性脑积水的诊断发生在出院后的第一年内。Cox比例风险分析确定,显微手术夹闭(风险比2.0;95%置信区间1.2 - 3.3)、临时脑室造瘘管置入(2.5;1.6 - 4.1)、机械通气(1.7;1.1 - 2.8)以及转至专业护理机构(2.9;1.8 - 4.6)与迟发性脑积水的发生显著相关。出院1年后,初始住院期间未进行临时脑室造瘘管置入的患者迟发性脑积水累积发生率为0.9%(95%CI,0.7 - 1.1%),而接受过临时脑室造瘘管置入的患者为5.7%(95%CI,3.9 - 8.1%)。
SAH后迟发性脑积水总体发生率较低,但在初始住院期间需要进行临时脑室造瘘术的患者中占相当比例。鉴于迟发性脑积水可能损害SAH后的恢复甚至导致临床恶化,这些结果支持对移除临时脑室造瘘管后的患者进行密切监测。